These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 869479)

  • 1. [Cerebral protecting activity of 1-eburnamonine studied on 3 models of acute hypoxic agression. Comparison with vincamine].
    Linée P; Perrault G; Le Pollès JB; Lacroix P; Aurousseau M; Boulu R
    Ann Pharm Fr; 1977; 35(3-4):97-106. PubMed ID: 869479
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebral metabolic, hemodynamic and antihypoxic properties of l-eburnamonine.
    Linée P; Lacroix P; Le Polles JB; Aurousseau M; Boulu R; Van den Driessche J; Albert O
    Eur Neurol; 1978; 17 Suppl 1():113-20. PubMed ID: 753626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the antihypoxic effect of eburnamonine in acute and recurrent anoxia on the cerebral electric activity in curarized rats. Comparison with vincamine].
    Van Den Driessche J; Linée P; Lacroix P; Le Pollès JB
    C R Seances Soc Biol Fil; 1977; 171(5):1081-7. PubMed ID: 146550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of vincamine on experimental cerebral infarction in Mongolian gerbils: a pilot study.
    Ritschel WA; Mandybur TI; Grummich KW; Means ED
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):131-4. PubMed ID: 6748817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental cerebral infarction in Mongolian gerbils: effects of vincamine on lesion size, survival and behavior.
    Ritschel WA; Mandybur TI; Grummich KW; Vorhees CV; Means ED
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):221-42. PubMed ID: 4023410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice.
    King GA
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):299-307. PubMed ID: 3592869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of Cetal in patients with acute confusion].
    Albert E
    Med Klin; 1979 Oct; Suppl():44-5. PubMed ID: 542166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of a cerebral oxygenator drug in chronic encephalopathies (apropos of the trial of vincamine)].
    Fossey F; Pasquier C
    Rev Neuropsychiatr Infant; 1972; 20(11):887-91. PubMed ID: 4650072
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
    Linquette M
    Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
    [No Abstract]   [Full Text] [Related]  

  • 12. [The neurotropic action of kavinton].
    Trepakov VV; Buldakova SL; Latanov AV; Saakian SA; Iashchenko EA
    Farmakol Toksikol; 1987; 50(4):29-33. PubMed ID: 3499349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia.
    Barzaghi F; Dragonetti M; Formento ML; Boissier JR
    Arzneimittelforschung; 1985; 35(2):472-7. PubMed ID: 4039569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of vincamine in intact and "encéphale isolé" fowl preparations.
    Nisticò G; Garcha GS; Olivieri G; Rotiroti D
    Acta Neurol (Napoli); 1978; 33(1):79-85. PubMed ID: 645453
    [No Abstract]   [Full Text] [Related]  

  • 15. Vincamine TPS activity on glycoconjugate metabolism of the brain: effect on lysosomal enzymes.
    Federico A; D'Amore I
    Int J Clin Pharmacol Res; 1984; 4(4):277-9. PubMed ID: 6500774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine.
    Fandy TE; Abdallah I; Khayat M; Colby DA; Hassan HE
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):259-67. PubMed ID: 26666648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative pharmacodynamic properties of apolar alkaloids of Vinca minor L. (Apocynaceae) (vincamine, vinca fraction and vinacamine free vinca fraction)].
    Quevauviller A; Foussard-Blandpin O; Le Men J; Thomann-Dumont G
    Sem Hop Ther; 1977 Mar; 53(3):145-51. PubMed ID: 877588
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modifications by 1-eburnamonine and vincamine on 2,3-diphosphoglycerate blood levels in the presence or absence of histotoxic hypoxia produced by potassium cyanide in the awake rat].
    Lacroix P; Linée P; Le Pollès JB
    C R Seances Soc Biol Fil; 1978; 172(2):330-6. PubMed ID: 150923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental electropharmacologic studies of cerebral ischemia (author's transl)].
    Depoortere H
    Rev Electroencephalogr Neurophysiol Clin; 1981; 10(3):207-14. PubMed ID: 7302319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypocapnia applied to study the effect of vincamine on cerebral circulation.
    Palacios L; Roca J; Balasch J
    Arch Farmacol Toxicol; 1978 Aug; 4(2):261-4. PubMed ID: 727839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.